Brief: Agile Therapeutics Announces Delisting From Nasdaq
25/03/2024 21:56
March 25 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS ANNOUNCES DELISTING FROM NASDAQ
* AGILE THERAPEUTICS INC - SUSPENSION OF TRADING IN
COMPANY'S
COMMON STOCK ON NASDAQ EXCHANGE WILL BE EFFECTIVE AT OPEN OF
TRADING ON MARCH 26, 2024
Source text for Eikon: ID:nGNX5cDvGS
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt